Santarus, Inc., a specialty pharmaceutical company, focuses on therapies that treat gastrointestinal diseases and disorders. Its products are immediate-release formulations of omeprazole, a proton pump inhibitor. The company markets two dosage forms, ZEGERID (omeprazole/sodium bicarbonate) Capsules and ZEGERID Powder for Oral Suspension, both of which are indicated for the treatment of heartburn and other symptoms associated with gastroesophageal reflux disease; the short-term treatment of erosive esophagitis diagnosed by endoscopy and active benign gastric ulcers; the short-term treatment of active duodenal ulcers; and for maintenance of healing of erosive esophagitis. ZEGERID Powder for...
To see the headquarters in Google Street View &trade, drag this yellow guy: 
over to the red pointer: 
